The customer-driven Dotmatics UGM gave users and partners the opportunity to discuss the future of scientific informatics
Bishops Stortford, UK. Dotmatics has successfully concluded its annual European User Group Meeting (UGM) in the United Kingdom. The annual event hosted more than 130 delegates from the pharmaceutical, biotech, chemical, agrochemical, academic and research industries. The two day meeting included lively discussions about the ability of the Dotmatics Platform to address multiple challenges including biologics and small molecule registration and tracking, biological screening, DMPK analysis, chemistry and biology ELNs, and project management.
Leading scientists from industry and academia presented their implementation of the Dotmatics Platform and the benefits that it has brought into their organizations. Presenters included AstraZeneca, Grünenthal, LEO Pharma, Cubist Pharmaceuticals, Cancer Research Technology, EBI-EMBL and the universities of Leeds, Sussex, Dundee and Newcastle.
One of the highlights of the meeting was the release of Elemental Draw. Dotmatics showcased the new Elemental Draw and Elemental apps, which attracted a lot of attention and enthusiastic comments from the audience. “We are very pleased with the feedback in response to Elemental Draw provided by the scientists at the UGM,” said Dr. Mike Hartshorn, CSO at Dotmatics. “The Elemental Suite provides a publication-quality chemistry drawing package that works on MAC OS, Windows and mobile platforms and addresses a clear challenge faced by chemists in different industries.”
Dotmatics’ CTO, Alastair Hill, presented the latest features and modules added during the last year and offered a view into the future development path of Dotmatics’ solutions. “We continue to invest in innovation and we are committed to leading the way in scientific informatics,” affirmed Alastair Hill. “Users’ feedback provides invaluable insights when blueprinting the expansion of our platform.”
“From the start, Dotmatics has placed a strong emphasis on the quality of its platform, services and strong relationship with users. The UGM emphasised the company’s uninterrupted commitment to listen to users, deliver on their needs and contribute to their success,” said Dr. Stephen Gallagher, Dotmatics CEO.” We are committed to delivering on the demands of today’s R&D organizations, by providing end-to-end solutions and complementing existing informatics infrastructures with key technology components.”
At the forefront of innovation, Dotmatics is a leading global scientific informatics software and services provider, delivering solutions tailored to the modern, highly collaborative and mobile pharmaceutical, biotechnology and chemical industries as well as academia. Dotmatics’ enterprise solutions are flexible, scalable and configurable, providing effective scientific information management across entire organizations, from discovery research to development and early manufacturing. Dotmatics has significant expertise in scientific informatics, including database management for chemistry and biologics, electronic laboratory notebooks, chemical and biological registration, screening data management, SAR analysis, reporting, and visualization. Dotmatics solutions are available for local or cloud deployment and they are supported on Microsoft Windows, MAC OS X and Linux. A privately owned company, Dotmatics was founded in 2005 and their headquarters is based south of Cambridge in the UK.